FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma

Approval Offers New Hope for Patients with Anti-PD-1 Refractory Melanoma Approval Offers New Hope for Patients with Anti-PD-1 Refractory Melanoma